Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #128360 on Amarantus Bioscience Holdings Inc (AMBS)
redspeed
06/16/18 4:37 PM
#128361 RE: JPetroInc #128360
Amarantus recently received an independent third-party valuation report which valued the Parkinson's disease levodopa-induced dyskinesia (PD-LID) indication for Eltoprazine in the US and Europe at $316 million.